Although amplification of TRIP-Br1 is commonly detected in ovarian cancers [16] and overexpression of TRIP-Br1 has been shown to induce tumors in nude mice [18], the role of its closely related family member, TRIP-Br2, in cell cycle regulation and tumor progression has not been elucidated. Here, CXCL11 is linked to ovarian carcinoma.